Stephen J. McCormack, PhD, has been appointed CEO of IMI Intelligent Medical Implants AG (Zug, Switzerland). McCormack was previously a partner of Global Life Science Ventures, where he led the firm's investment in IMI. Prior to Global Life Science Ventures, he cofounded NeuroSystec Corp. (Valencia, CA), a company focused on the development of therapeutics to treat neurological diseases, and AlleCure, which was merged with two other biotechnology companies and taken public as MannKind Corp. (Valencia, CA).
Donal Quinn has been appointed as the new head of the diagnostics division of Siemens Healthcare (Erlangen, Germany). In his new position, Quinn succeeds Jim Reid-Anderson, who on May 1 became the new CEO of the sector. Prior to his new position, Quinn had served as executive vice president and chief customer officer of the diagnostics division since November 2007. Quinn has held many roles during his long career in the healthcare industry. After serving as controller for Abbott Laboratories, Ireland, in the late 1970s, Quinn worked 16 years for Mallinckrodt Medical (Hennef, Germany). In 1998, Quinn joined Dade Behring as group president for biology and subsequently held multiple executive titles of increasing responsibility. Dade Behring was acquired by Siemens in 2007.
CoreValve Corp. (Irvine,CA) has appointed Vito A. Canuso III as vice president of intellectual property. In this position, Canuso's immediate focus will include managing the company's worldwide patent litigation with Edwards Lifesciences (Irvine, CA). Canuso joins CoreValve from Knobbe, Martens, Olson & Bear LLP, where he had been a partner since 1995.